US Stock MarketDetailed Quotes

BRNS Barinthus Biotherapeutics

Watchlist
  • 0.895
  • -0.094-9.47%
Close Nov 22 16:00 ET
  • 0.895
  • 0.0000.00%
Post 20:01 ET
35.99MMarket Cap-600P/E (TTM)

Barinthus Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-62.61%-18.2M
29.20%-12.01M
-272.46%-11.82M
-252.89%-50.93M
-72.82%-19.6M
-194.17%-11.19M
-102.04%-16.96M
51.76%-3.17M
55.71%-14.43M
-42.29%-11.34M
Net income from continuing operations
42.39%-8.13M
28.88%-16.94M
14.83%-15.52M
-1,480.32%-73.45M
18.30%-17.29M
-271.63%-14.11M
-251.85%-23.82M
-807.96%-18.22M
110.41%5.32M
-39.50%-21.16M
Operating gains losses
141.73%2.61M
-87.76%443K
-129.28%-1.03M
129.82%7.53M
-43.01%6.65M
65.69%-6.24M
--3.62M
--3.5M
-432.89%-25.25M
--11.67M
Depreciation and amortization
0.07%1.48M
12.93%1.47M
17.12%1.43M
25.58%5.43M
21.92%1.44M
24.07%1.47M
30.95%1.3M
26.40%1.22M
618.11%4.32M
266.67%1.18M
Deferred tax
99.50%-3K
99.38%-7K
92.83%-37K
29.10%-3.08M
57.55%-821K
3.68%-602K
-24.15%-1.14M
40.21%-516K
-3,544.54%-4.34M
-3,292.98%-1.93M
Other non cash items
108.33%2K
-30.87%383K
18.41%431K
21.43%1.41M
191.18%517K
-104.17%-24K
-28.15%554K
-4.96%364K
0.96%1.16M
-262.93%-567K
Change In working capital
-285.20%-15.29M
168.63%1.46M
-84.43%1.29M
211.71%6.17M
-323.42%-10.88M
-57.91%8.26M
106.06%542K
160.59%8.25M
23.04%-5.52M
-185.47%-2.57M
-Change in receivables
-1,510.14%-15.55M
429.46%683K
-104.69%-331K
221.35%5.67M
-270.68%-553K
-108.30%-966K
-68.69%129K
141.42%7.06M
-53.38%-4.68M
145.06%324K
-Change in prepaid assets
-14.99%1.82M
-64.09%-1.61M
-54.16%1.88M
201.38%2.2M
-491.40%-3.05M
-30.25%2.14M
79.93%-983K
464.85%4.09M
48.59%-2.17M
-38.81%779K
-Change in payables and accrued expense
-131.23%-2.28M
150.11%3.45M
55.43%-1.35M
-173.24%-1.39M
-112.12%-7.04M
48.21%7.29M
132.26%1.38M
-166.14%-3.02M
112.71%1.89M
-235.00%-3.32M
-Change in other current assets
--0
--0
--0
133.07%128K
193.06%201K
---211K
108.98%15K
3,175.00%123K
47.35%-387K
-2,063.64%-216K
-Change in other current liabilities
---487K
---473K
---346K
---445K
---445K
--0
--0
--0
--0
----
-Change in other working capital
--1.21M
---595K
--1.43M
----
----
----
----
----
-190.48%-183K
-833.33%-140K
Cash from discontinued investing activities
Operating cash flow
-62.61%-18.2M
29.20%-12.01M
-272.46%-11.82M
-252.89%-50.93M
-72.82%-19.6M
-194.17%-11.19M
-102.04%-16.96M
51.76%-3.17M
55.71%-14.43M
-42.29%-11.34M
Investing cash flow
Cash flow from continuing investing activities
-216.67%-114K
93.65%-192K
87.71%-308K
5.86%-5.41M
126.11%153K
98.22%-36K
-47.18%-3.02M
-129.58%-2.51M
55.47%-5.75M
95.19%-586K
Net PPE purchase and sale
-216.67%-114K
93.65%-192K
87.71%-308K
5.86%-5.41M
126.11%153K
98.22%-36K
-47.18%-3.02M
-129.58%-2.51M
-401.75%-5.75M
-38.21%-586K
Cash from discontinued investing activities
Investing cash flow
-216.67%-114K
93.65%-192K
87.71%-308K
5.86%-5.41M
126.11%153K
98.22%-36K
-47.18%-3.02M
-129.58%-2.51M
55.47%-5.75M
95.19%-586K
Financing cash flow
Cash flow from continuing financing activities
910.87%465K
1,178.57%358K
-70.22%503K
476.00%1.87M
-77.48%109K
46K
28K
1,162.26%1.69M
-99.85%325K
5,277.78%484K
Net issuance payments of debt
----
----
----
--0
----
----
----
----
---159K
--0
Net common stock issuance
910.87%465K
293.41%358K
-71.88%503K
320.45%2.04M
-77.48%109K
--46K
--91K
--1.79M
-99.53%484K
268.64%484K
Proceeds from stock option exercised by employees
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Net other financing activities
----
----
----
---163K
--0
--0
---63K
---100K
----
----
Cash from discontinued financing activities
Financing cash flow
910.87%465K
1,178.57%358K
-70.22%503K
476.00%1.87M
-77.48%109K
--46K
--28K
1,162.26%1.69M
-99.85%325K
5,277.78%484K
Net cash flow
Beginning cash position
-31.93%117.77M
-32.07%129.97M
-26.90%142.09M
-9.19%194.39M
-19.89%160.31M
-10.03%173.03M
-4.62%191.33M
-9.19%194.39M
394.74%214.05M
-14.44%200.1M
Current changes in cash
-59.62%-17.85M
40.66%-11.84M
-191.26%-11.63M
-174.30%-54.47M
-68.99%-19.34M
-213.33%-11.18M
-90.98%-19.95M
49.02%-3.99M
-111.20%-19.86M
43.21%-11.45M
Effect of exchange rate changes
500.97%6.18M
-121.58%-357K
-152.62%-492K
1,060.96%2.17M
-80.41%1.12M
26.28%-1.54M
-24.06%1.65M
116.61%935K
102.90%187K
1,604.17%5.73M
End cash Position
-33.81%106.1M
-31.93%117.77M
-32.07%129.97M
-26.90%142.09M
-26.90%142.09M
-19.89%160.31M
-10.03%173.03M
-4.62%191.33M
-9.19%194.39M
-9.19%194.39M
Free cash flow
-63.11%-18.31M
38.95%-12.2M
-113.52%-12.13M
-173.90%-56.34M
-63.05%-19.45M
-218.45%-11.23M
-91.25%-19.98M
25.94%-5.68M
39.02%-20.57M
-42.08%-11.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -62.61%-18.2M29.20%-12.01M-272.46%-11.82M-252.89%-50.93M-72.82%-19.6M-194.17%-11.19M-102.04%-16.96M51.76%-3.17M55.71%-14.43M-42.29%-11.34M
Net income from continuing operations 42.39%-8.13M28.88%-16.94M14.83%-15.52M-1,480.32%-73.45M18.30%-17.29M-271.63%-14.11M-251.85%-23.82M-807.96%-18.22M110.41%5.32M-39.50%-21.16M
Operating gains losses 141.73%2.61M-87.76%443K-129.28%-1.03M129.82%7.53M-43.01%6.65M65.69%-6.24M--3.62M--3.5M-432.89%-25.25M--11.67M
Depreciation and amortization 0.07%1.48M12.93%1.47M17.12%1.43M25.58%5.43M21.92%1.44M24.07%1.47M30.95%1.3M26.40%1.22M618.11%4.32M266.67%1.18M
Deferred tax 99.50%-3K99.38%-7K92.83%-37K29.10%-3.08M57.55%-821K3.68%-602K-24.15%-1.14M40.21%-516K-3,544.54%-4.34M-3,292.98%-1.93M
Other non cash items 108.33%2K-30.87%383K18.41%431K21.43%1.41M191.18%517K-104.17%-24K-28.15%554K-4.96%364K0.96%1.16M-262.93%-567K
Change In working capital -285.20%-15.29M168.63%1.46M-84.43%1.29M211.71%6.17M-323.42%-10.88M-57.91%8.26M106.06%542K160.59%8.25M23.04%-5.52M-185.47%-2.57M
-Change in receivables -1,510.14%-15.55M429.46%683K-104.69%-331K221.35%5.67M-270.68%-553K-108.30%-966K-68.69%129K141.42%7.06M-53.38%-4.68M145.06%324K
-Change in prepaid assets -14.99%1.82M-64.09%-1.61M-54.16%1.88M201.38%2.2M-491.40%-3.05M-30.25%2.14M79.93%-983K464.85%4.09M48.59%-2.17M-38.81%779K
-Change in payables and accrued expense -131.23%-2.28M150.11%3.45M55.43%-1.35M-173.24%-1.39M-112.12%-7.04M48.21%7.29M132.26%1.38M-166.14%-3.02M112.71%1.89M-235.00%-3.32M
-Change in other current assets --0--0--0133.07%128K193.06%201K---211K108.98%15K3,175.00%123K47.35%-387K-2,063.64%-216K
-Change in other current liabilities ---487K---473K---346K---445K---445K--0--0--0--0----
-Change in other working capital --1.21M---595K--1.43M---------------------190.48%-183K-833.33%-140K
Cash from discontinued investing activities
Operating cash flow -62.61%-18.2M29.20%-12.01M-272.46%-11.82M-252.89%-50.93M-72.82%-19.6M-194.17%-11.19M-102.04%-16.96M51.76%-3.17M55.71%-14.43M-42.29%-11.34M
Investing cash flow
Cash flow from continuing investing activities -216.67%-114K93.65%-192K87.71%-308K5.86%-5.41M126.11%153K98.22%-36K-47.18%-3.02M-129.58%-2.51M55.47%-5.75M95.19%-586K
Net PPE purchase and sale -216.67%-114K93.65%-192K87.71%-308K5.86%-5.41M126.11%153K98.22%-36K-47.18%-3.02M-129.58%-2.51M-401.75%-5.75M-38.21%-586K
Cash from discontinued investing activities
Investing cash flow -216.67%-114K93.65%-192K87.71%-308K5.86%-5.41M126.11%153K98.22%-36K-47.18%-3.02M-129.58%-2.51M55.47%-5.75M95.19%-586K
Financing cash flow
Cash flow from continuing financing activities 910.87%465K1,178.57%358K-70.22%503K476.00%1.87M-77.48%109K46K28K1,162.26%1.69M-99.85%325K5,277.78%484K
Net issuance payments of debt --------------0-------------------159K--0
Net common stock issuance 910.87%465K293.41%358K-71.88%503K320.45%2.04M-77.48%109K--46K--91K--1.79M-99.53%484K268.64%484K
Proceeds from stock option exercised by employees --0--0--0--0--0--0--0--0--0--0
Net other financing activities ---------------163K--0--0---63K---100K--------
Cash from discontinued financing activities
Financing cash flow 910.87%465K1,178.57%358K-70.22%503K476.00%1.87M-77.48%109K--46K--28K1,162.26%1.69M-99.85%325K5,277.78%484K
Net cash flow
Beginning cash position -31.93%117.77M-32.07%129.97M-26.90%142.09M-9.19%194.39M-19.89%160.31M-10.03%173.03M-4.62%191.33M-9.19%194.39M394.74%214.05M-14.44%200.1M
Current changes in cash -59.62%-17.85M40.66%-11.84M-191.26%-11.63M-174.30%-54.47M-68.99%-19.34M-213.33%-11.18M-90.98%-19.95M49.02%-3.99M-111.20%-19.86M43.21%-11.45M
Effect of exchange rate changes 500.97%6.18M-121.58%-357K-152.62%-492K1,060.96%2.17M-80.41%1.12M26.28%-1.54M-24.06%1.65M116.61%935K102.90%187K1,604.17%5.73M
End cash Position -33.81%106.1M-31.93%117.77M-32.07%129.97M-26.90%142.09M-26.90%142.09M-19.89%160.31M-10.03%173.03M-4.62%191.33M-9.19%194.39M-9.19%194.39M
Free cash flow -63.11%-18.31M38.95%-12.2M-113.52%-12.13M-173.90%-56.34M-63.05%-19.45M-218.45%-11.23M-91.25%-19.98M25.94%-5.68M39.02%-20.57M-42.08%-11.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data